Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06429332 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

International Care Bundle Evaluation in Cerebral Hemorrhage Research

Study acronym: I-CATCHER
StatusRecruiting
PhasePhase 4
Started2025-01-07
View on ClinicalTrials.gov ↗

Amendment history

2026-05-20
minor
Study Status, Contacts/Locations v3
Study sites52→54
2026-02-06
minor
Study Status, Contacts/Locations v2
Completion date2027-09→2027-07
Study sites14→52
2025-05-30
notable
Not Yet Recruiting→Recruiting Study Status, Sponsor/Collaborators, Arms and Interventions, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2026-10-01→2027-03-01
Completion date2027-03-31→2027-09
Start dateestimated 2024-09-01→confirmed 2025-01-07
Study sites2→14
Collaborators1 to 2 entries
Ottawa Hospital Research Institute
2024-05-20
minor
Original filing
146 trials monitored
See 5 trials at risk
3,268 trials monitored
See 122 trials at risk
Spontaneous intracerebral haemorrhage (ICH) accounts for approximately 10-15% of all strokes but stands for 50% of stroke-related morbidity and mortality. Approximately half of all patients with ICH have a decreased level of consciousness at hospital admission. Despite this, intensive care and neurosurgical interventions are uncommon. A study conducted in low- and middle-income countries has demonstrated a beneficial effect of a treatment package consisting of early intensive blood pressure lowering, as well as the treatment of pyrexia and elevated blood glucose levels. The I-CATCHER team is now planning to conduct a similar study in Sweden and Australia, as well as in other high-income countries. The study has a clear focus on implementation, aiming to improve treatment and prognosis for patients with ICH within a few years. The purpose of I-CATCHER is to investigate whether a structured treatment package (Care Bundle) improves 3-month prognosis in patients with spontaneous ICH compared to standard care.
Trial Details
NCT Number NCT06429332
Lead Sponsor Region Skane
Collaborators: The George Institute for Global Health, Australia, Ottawa Hospital Research Institute
Conditions Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage, Stroke, Cerebrovascular Disease
Enrollment 3,500 participants
Start Date 2025-01-07
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-22